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Objective: The aim of this study was to assess the effect of the 
family physician on improving compliance with follow-up of 
abnormal smears in cervical cancer screening.
Design: Observational study.
Setting: Two Regional Health Authority districts in the east of 
The Netherlands.
Study participants: Family practices with a national call system 
for cervical cancer screening and family practices with a family- 
practice-based call system. In a number of practices the family 
physicians had introduced a fail-safe system for follow-up.
Main outcome measures: Follow-up of women who participated 
in the first screening round and in whom a cytological abnormality 
had been diagnosed in the first smear. Criteria for adequate 
follow-up were defined with regard to the severity of the 
cytological abnormality.
Results: The overall compliance with follow-up in the study- 
group was 88%. The study showed a strong relationship between 
involvement of the family physician and compliance with follow- 
up. The compliance in practices that had a fail-safe system for 
follow-up was 93% compared to 82% in the practices without a 
fail-safe system. The highest follow-up was found in practices 
involved in the family-practice-based system. ©  1997 Elsevier 
Science Ltd.
Key words: Screening, cervical cancer, call system, follow- 
up, family-practice-based call system, family physician, 
organization, computerization.
INTRODUCTION
Mortality from cancer of the cervix can be reduced by 
cytological screening. The Nordic countries of Europe 
with carefully organized screening programmes, have 
shown a sharp reduction both in incidence of and 
mortality from cervical cancer since the mid-1960s, 
when mass screening started [1]. The crucial question 
for the success of cervical cancer screening is one of 
organization, to ensure high participation, an adequate
follow-up of cytological abnormalities and good smear 
taking.
In The Netherlands, a nationwide screening pro­
gramme for cervical cancer was started in 1989. Every 
3 years, all women aged between 35 and 54 years are 
invited for a cervical smear. In this nationwide pro­
gramme the Regional Health Authority invites the 
women and the family physician takes the smears. 
Under these conditions, monitoring of and responsibility 
for participation is a major problem. Thus far, the 
attendance rate of this nationwide screening programme 
has been disappointing, ranging from 40 to 50%.
Another problem is the responsibility for the follow-up 
of women with pre-invasive cytological abnormalities. 
The laboratory will advise on follow-up actions, which 
have to be performed by the family physician. Again, the 
responsibility for supervision is not regulated. Compli­
ance with follow-up of the women who participated in the 
nationwide programme has not yet been investigated.
The quality of cervical smears taken by family 
physicians in the national screening programme has 
been evaluated in the region of Nijmegen. The results of 
this study show that the quality of smears taken by family 
physicians has improved since the start of the national 
screening programme [2].
A system in which the family physician will be 
responsible for invitations to receive a PAP smear, is an 
option for improvement of the screening programme. 
Therefore, in 1989 an intervention study with a family- 
practice-based call system started in the Regional Health 
Authority district in the east of The Netherlands, to 
evaluate the effect of this call system on attendance rate 
and compliance with follow-up. The intervention group 
consisted of nine computerized family practices; women 
from these practices were invited for cervical cancer 
screening by a personal letter from their own family 
physician. The control group consisted of the other 
practices in the region without a family-practice-based 
call system. In these practices the women were invited by 
the Regional Health Authority (national call system).
The family-practice-based call system resulted in a 
higher attendance rate than the national call system. The 
attendance rate in the intervention group was 55% 
compared to 43% in the control group. A reminder in
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the family-practice-based call system increased the 
attendance rate by an additional 9% [3],
This paper deals with the compliance with follow-up. 
First we assessed the extent of compliance with follow-up 
of cytological abnormalities among all women partici­
pating in screening in two Regional Health Authority 
districts in the east of The Netherlands. Secondly we 
evaluated the effect of the involvement of the family 
physician on compliance with follow-up. Our expectation 
was that involvement of the family physicians in a family- 
practice-based call system for invitations to receive a 
PAP smear, would increase their involvement in ensuring 
adequate follow-up.
procedures within reasonable margins of the indicated 
interval were classified as “optimal follow-up”. Women 
who completed the recommended follow-up but after the 
reasonable interval were classified as “sub-optimal 
follow-up”. Women who failed to return, or only 
returned after a period of 12 months were defined as 
“lost to follow-up” (Table 1),
Data about compliance with follow-up were obtained 
from the national data bank of the pathology labora­
tories. All women were traced for a minimum of 
12 months after the date of the abnormal PAP smear. 
Information was collected on all recommended follow-up 
procedures, whether they were performed, and, if so, on 
what date.
METHODS
Compliance with follow-up
As data on the smear results were collected from the 
regional cytological laboratory, this study was confined 
to the family practices that sent their smears to the 
Nijmegen laboratory (86 family practices).
Included in the follow-up study were all women 
registered in these practices who participated in the first 
screening round (1989-1991) and in whom a cytological 
abnormality had been diagnosed in the first smear. This 
selection was made by the regional laboratory. At the 
laboratory, information was obtained about the age of 
the woman, her marital status, the family physician with 
whom a woman was registered, and about PAP smear 
results with recommendation for follow-up.
Criteria for adequate follow-up were defined with 
regard to the severity of the cytological abnormality. 
The national screening programme includes clear guide­
lines for the follow-up of abnormal smears [4]. In case of 
a positive smear, the laboratory gives recommendations 
to the family physician for follow-up. The interval at 
which a repeat smear was recommended depended on the 
classification of the smear. For mild and moderate 
dysplasia a first repeat smear was recommended after 
3 months. For severe dysplasia a first repeat smear was 
recommended after 1 month or the women were referred 
to a gynaecologist. Women with a cytological diagnosis 
consistent with carcinoma in situ or invasive cancer had 
to be referred for histological analysis.
Women who completed the recommended follow-up
Involvement of the family physicians
Women registered with nine family practices in these 
regions received an invitation for cervical cancer screen­
ing from their family physician (family-practice-based 
call system). Women registered with the other 77 family 
practices of the regions were invited by the Regional 
Health Authorities (national call system).
In all practices the family physician took the smears. In 
a number of practices the family physicians had intro­
duced a system for monitoring and surveillance of follow- 
up of women with cytological abnormalities, a fail-safe 
system. Data about the presence of a fail-safe system in 
the nine family practices with the family-practice-based 
call system were known from the intervention study. In 
the 77 family practices with the national call system these 
data were known in 45 practices from a postal survey 
conducted in part of the study region [5]. No data 
regarding monitoring and surveillance were known for 
the remaining 35 practices. Therefore these practices were 
excluded from analyses concerning involvement of family 
physicians and compliance with follow-up.
ANALYSIS
In a univariate analysis the relationship was assessed 
between known characteristics of the women (age, 
marital status and PAP smear results) and compliance 
with follow-up.
To evaluate the effect of the family physician’s 
involvement, the follow-up of abnormal smears was
TABLE 1. Definition of follow-up
M >  1 1 1  . . . . . . . . . . . . . . . . . . . . . . . . . . *  .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  | M "  1 1  "  l . w  —  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  i  *  —  i U m m m  ■  ■  i  m 1 1 1  n  |  W »  n  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ■ ■  m  —  n  i i » H i -  . . . . . . . . . . . . . . . . . . . . . . . . .  »  i  ■ ■  ■ ■ ■  1 —
Recommended interval N % Optimal follow-up Sub-optimal follow-up Lost to follow-up
(Interval to repeat examination in months)
1 month or after short period 86 16.8 < = 3 4-12 >12
After treatment of inflammatory changes 4 0.8 <  = 6 7-12 >12
3 months 320 62.6 < = 5 6-12 >12
6 months 48 9.4 <  - 9 10-12 > 12
Referral for histological analysis 35 6.9 < * 3 4-12 >12
1 month or referral for histological analysis 18 3.5 < - 3 4-12 >12
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compared between practices with and without a fail-safe 
system, and practices with and without the family- 
practice-based call system.
A logistic regression was performed to correct for 
potential confounders on the involvement effects: The 
involvement effects were defined as the effect of a fail-safe 
system (both in the practices with the family-practice- 
based call system and in those with the national call 
system) and the effect of involvement in a call system. For 
this analysis the outcome measure was dichotomized into 
women with optimal follow-up versus women with sub- 
optimal follow-up or without follow-up. The involve­
ment effects and all significant characteristics of the 
women were included in a stepwise logistic regression 
model: a fail-safe system, a family-practice based system, 
age 43 years and younger, severe dysplasia or higher. 
Only variables that met the 0.15 significance level are 
included in the model.
RESULTS
Initially 586 women were selected on the basis of a 
report of cellular abnormality. Seventy-five women were 
excluded because of a previous abnormal smear. The 
study therefore included 511 women. Smears were 
classified as mild dysplasia (« = 335; 66%), moderate 
dysplasia (« = 77; 15%), severe dysplasia (« = 56; 11%), 
carcinoma in situ (« = 41; 8%) and (micro) invasive 
cancer (n = 2).
Overall, 76% of the population were classified as 
optimal follow-up; 12% as sub-optimal follow-up and 
12% as being lost to follow-up. Women who failed to 
comply with follow-up were more likely to be older and 
to have a less severe degree of cytological abnormality 
than women who returned for follow-up (Table 2). There
►
was no relation between marital status and compliance 
with follow-up.
For further analysis 205 women registered in 35 
practices with the national call sytem were excluded. No 
data regarding monitoring and surveillance of follow-up 
were known for these practices. The remaining 306
women consisted of 53 women registered with 9 practices
with the family-practice-based call system and 253
women registered with 42 practices with the national 
call system.
All the practices with the family-practice-based call 
system had a fail-safe system for follow-up. They sent an 
invitation for follow-up or contacted women who did not 
respond to recommended repeat smears or histological 
analysis. In the intervention study the time spent on such 
a fail-safe system was only 2-3 hours a year [6].
Of the practices with the national call system 50% also 
had such a fail-safe system.
There was a relationship between involvement of the 
family physician and compliance with follow-up. Com­
pliance in practices with a fail-safe system was 93% 
compared to 82% in the practices without a fail-safe 
system; optimal follow-up was 81% compared to 65%. 
The highest compliance was found among the women 
registered with the practices with the family-practice- 
based call system (Table 3).
Table 4 shows the odds ratios derived from the logistic 
regression model. The following factors had an indepen­
dent association with follow-up: severity of initial 
cytological abnormality and the presence of a fail-safe 
system for follow-up in the practice. There is no 
independent effect of involvement in the family-prac- 
tice-based call system.
The age of women did not independently contribute to 
the consistency of follow-up of abnormal smears.
Figure 1 shows the compliance related to the involve­
ment of the family physician with whom a woman was 
registered as well as to the severity of the abnormality of 
the initial smear.
DISCUSSION
This study shows that family physicians who are 
involved in inviting women to participate in a screening 
programme for cervical cancer, are more successful in 
obtaining follow-up of abnormal smears than family 
physicians not involved in the initial screening invitation.
TABLE 2. Follow-up according to age, marital status and PAP smear results
N Optimal
follow-up
Sub-optimal
follow-up
Lost to follow- 
up
x2 P value
N % N % N %
Age
25 8.943 and under 281 225 80.1 31 11.0
44 and over 230 162 70.4 33 14.4 35 15.2 6.96 0.031
Marital status*
Married 377 283 75.1 49 13.0 45 11.9
Unmarried 44 32 72.7 6 13.65 6 13.65 0.14 0.935
PAP smear results
Mild-moderate dysplasia 412 300 72.8 57 13.8 55 13.4
9.99 0.007Severe dysplasia or higher 99 87 87.9 7 7.1 5 5.0
90 women: marital status unknown.
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TABLE 3. Follow-up and involvement of the family physician
N  Optimal Sub-optimal Lost to %2 p value
follow-up follow-up follow-up
N % N % N %
Practices with a fail-safe system:
Family-practice-based call system 53 45 84.9 6 11.3 2 3,8
National call system 140 111 79.3 17 12.1 12 8.6
Practices without a fail-safe system:
National call system 113 74 65.5 19 16.8 20 17.7 11.45 0.02
Total 306 230 75.2 42 13.7 34 11.1
TABLE 4. Logistic regression
Partial R2 Model R2 C(p) F Prob > F
1. Fail-safe system 0.029 0.029 8,317 9.038 0.0029
2. Severe dysplasia or higher 0.024 0.053 2.805 7.518 0.0065
Stepwise logistic regression model with the following variables: a fail-safe system, a family-practice based system, age 43 years and 
younger, a severe dysplasia or higher. Only variables that met the 0.15 significance level are included in the model.
Successful follow-up was related to the severity of 
abnormality of the initial smear as well to the willingness 
of the family physician to monitor follow-up.
The family practices which had introduced a fail-safe 
system for follow-up were more successful in compliance 
with follow-up compared to practices without a fail-safe 
system. This is true for all women who had a cytological 
abnormality in the initial smear. However, the differences 
become even more clear when the women are categorized 
according to the severity of the abnormality. The fail-safe 
system had an effect for women with a severe dysplasia as 
well as for women with a mild/moderate dysplasia in the 
initial smear (Figure 1).
The highest proportion of compliance with follow-up 
was found in the practices that were also involved in the 
call system. To a large extent the effect of the involvement 
in the call system can be explained by the presence of a
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FIGURE 1. Compliance with follow-up by involvement of 
family physician and severity of smear.
fail-safe system in all these practices. We believe that the 
involvement of family physicians in a family-practice- 
based call system had a stimulating effect on the 
introduction of a fail-safe system within the practices as 
well as on the responsibility of the family physician for 
adequate follow-up.
The compliance with follow-up among the women 
registered with practices without a fail-safe system was 
consistent with results from other studies. Eighty-two per 
cent of the women returned for follow-up, 65.5% with 
optimal follow-up. These findings are comparable to, or 
better than, those from other studies in which, although 
the definitions of follow-up varied, compliance was not 
higher than 60-70%. Elwood et ah [7] found satisfactory 
follow-up for fewer than 60%) of women diagnosed with 
cervical abnormalities on PAP smears. Satisfactory 
follow-up was defined as: gynaecological referral and 
further assessment or treatment, and, for mild or 
moderate cases, two consecutive normal smears.
In a study by Mitchell and Medley [8], 63% of the 
women with mild to severe dysplasia were rescreened. In 
a large randomized trial Marcus et a i  [9] showed that 
nearly 30% of women who had abnormal PAP smears 
failed completely to return for follow-up.
In this study compliance with follow-up was strongly 
related to the severity of the initial PAP smear. Among 
women with severe dysplasia or higher only 5% did not 
return for follow-up. Among women with mild to 
moderate dysplasia the percentage lost to follow-up was 
much higher.
The influence of the severity of the initial abnormality 
on follow-up in this study was consistent with the results 
of other studies [9,10], but the influence of the woman’s 
age and marital status that have been reported [8,9] could 
not be confirmed.
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Several factors influenced the results of this study. The 
introduction of a family-practice-based call system 
depended on the availability of a computerized system 
in the practice. Placing practices in a family-practice- 
based system was therefore not random. In these 
practices the family physicians and their staff were 
actively involved in the call system. Though there were 
no indications [3,5,11] that this group initially had a 
different attitude to cervical screening or towards an 
active role in prevention in general, such a selection bias 
cannot be ruled out. This may have resulted in the 
introduction of a “fail-safe” system, which all practices 
with the family-based-call system introduced on their 
own initiative. The principles of the family-practice-call 
system were known to the non-participating practices in 
the region, and this, again, may have influenced their 
attitudes. This may have resulted in the implementation 
of a self-initiated “fail-safe” system in some of the 
practices with the national call system.
Follow-up can be improved by sending reminders and 
by giving better information to the women. In a study by 
Michielutte et aL [10] in which non-compliant women 
were sent one or two reminders, the follow-up was 83%. 
A positive effect of reminders was also found in Mitchell 
and Medley’s study; a reminder letter increased follow-up 
from 63 to 85% [8]. Another attempt to increase 
compliance was made in the intervention study of 
Marcus et a i , in which a personalized follow-up 
combined with targeted information had a positive 
impact on follow-up [9].
The laboratory can play an important role in monitor­
ing follow-up. During the pilot programmes carried out 
in three regions in The Netherlands from 1976 to 1986 
[12,13], the laboratory initiated a fail-safe procedure to 
ensure that family physicians did not forget to repeat 
smears after the recommended interval. Linking the 
computerized laboratory to the computerized general 
practice could further facilitate supervision of follow-up 
of abnormal smears.
In the period of this study the regional laboratory 
monitored the compliance of women with severe dyspla­
sia. This surveillance undoubtedly contributed to the 
high compliance within this group. As a result, women 
with a more severe degree of cytological abnormality 
were more likely to return for follow-up. Even under 
these relatively good circumstances the extra value of a 
fail-safe system within the practice stands out clearly.
This study showed that introduction of a fail-safe 
system for follow-up in a family practice resulted in 
higher compliance with follow-up. The best results of 
follow-up were found in practices that were also involved 
in the call system. We believe that involvement in the 
family-practice-based system also increases responsibility 
for follow-up. All these practices had introduced a fail­
safe system and were conscientious in the execution of 
this system.
In the nationwide screening programme follow-up can 
be improved by a higher level of involvement by family
physicians. One option is the introduction of a family- 
practice-based call system. This model appears feasible 
on a larger scale in The Netherlands and in other 
countries where data from practice lists are available [3]. 
But in all practices where family physicians take the 
smears for screening they are also responsible for 
adequate follow-up. Therefore the government has to 
stimulate the introduction of a fail-safe system for follow- 
up in all these practices. The introduction of such a 
system is simple and does not take much time.
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